FDA authorizes second booster shot for people age 50 and up

The Food and Drug Administration (FDA) gave the green light on Tuesday, March 29 to a second coronavirus vaccine booster shot for people aged 50 and older in an effort to ward off another potential spike in infections due to a subvariant of omicron.

The agency granted emergency use authorization to the vaccines from Pfizer as well as Moderna. Pfizer had initially requested authorization for people aged 65 and older, while Moderna requested broader authorization for all adults.


Topics: Vaccine

Written by Argentum

Subscribe to Instant Email Updates

See More COVID-19 Announcements

Read more announcements related to COVID-19 on our Coronavirus Blog and access more information on:


Stay Updated on COVID-19

Find all of our latest updates on developments related to COVID-19 on our Coronavirus Toolkit.